Recent Updates
Recently added Catalysts
EBS Positive Sentiment

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

Thursday, February 29, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Emergent BioSolutions Inc. will conduct a conference call on March 6, 2024, to discuss its financial results for the fourth quarter and full year of 2023. Newly appointed president and CEO Joseph C. Papa is set to provide remarks during the call. Investors can access the meeting live through a webcast or via telephone, with necessary registration details provided. A replay of the call will be available on the company's website after the event.
Price reaction · baseline $3.2 (2024-02-28 close) · hit after-hours · clean, no other EBS news in the window
day 0 close
+0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions is set to report their financial results, indicating ongoing business activity.
  • The newly appointed CEO, Joseph C. Papa, is taking an active role in the financial presentation.
  • The conference call format allows for direct engagement with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
8%
average across 2 past catalysts
Lead asset
FLU-IGIV
Phase 2 · Influenza A H3N2

Full Press Release Details

GAITHERSBURG, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, March 6, 2024, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year 2023. Emergent’s newly appointed president and CEO, Joseph C. Papa, will provide remarks.
Conference Call Information
Participants can access the conference call live via webcast from the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
Executive Vice President, CFO

Frequently Asked Questions

When is Emergent BioSolutions' conference call scheduled?

The conference call is set for March 6, 2024, at 5:00 pm ET.

Who will speak at the conference call?

Joseph C. Papa, the new president and CEO, will give remarks.

How can I access the conference call?

Participants can join the call via webcast or by telephone after registering.

Is there a replay available for the conference call?

Yes, a replay can be accessed on the Investors page of Emergent's website.

ShareAdd on Google
Tags: EBS Viatris Investor Conferences Healthcare Emergent BioSolutions financial results conference call 2023
Last updated: Feb 29, 2024

Biotech snapshot

Cash runway
$141M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FLU-IGIVPhase 2
Influenza A H3N2 →

Catalyst track record

+70%
best trade around EBS's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for EBS.

See every catalyst's timing & PoA →